Rua Bioscience Limited (RUA.NZ)
NZD 0.03
(0.0%)
NZD 0.03
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -13.71 Million NZD | -130.21% |
| 2023 | -5.95 Million NZD | 31.0% |
| 2022 | -8.63 Million NZD | -81.93% |
| 2021 | -4.74 Million NZD | -68.75% |
| 2020 | -2.81 Million NZD | -42.92% |
| 2019 | -1.96 Million NZD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -13.71 Million NZD | -130.21% |
| 2024 Q2 | -10.85 Million NZD | -100.0% |
| 2024 Q4 | -2.86 Million NZD | 0.0% |
| 2024 Q1 | -5.42 Million NZD | 18.75% |
| 2023 FY | -5.95 Million NZD | 31.0% |
| 2023 Q2 | 718.7 Thousand NZD | 100.0% |
| 2023 Q4 | -6.67 Million NZD | -100.0% |
| 2023 Q1 | 359.35 Thousand NZD | 105.82% |
| 2023 Q3 | -3.33 Million NZD | -564.59% |
| 2022 Q1 | -1.23 Million NZD | 40.88% |
| 2022 FY | -8.63 Million NZD | -81.93% |
| 2022 Q4 | -6.17 Million NZD | -100.0% |
| 2022 Q3 | -3.08 Million NZD | -25.18% |
| 2022 Q2 | -2.46 Million NZD | -100.0% |
| 2021 FY | -4.74 Million NZD | -68.75% |
| 2021 Q4 | -2.08 Million NZD | -100.0% |
| 2021 Q3 | -1.04 Million NZD | 55.33% |
| 2021 Q2 | -2.33 Million NZD | -100.0% |
| 2021 Q1 | -1.16 Million NZD | 24.01% |
| 2020 FY | -2.81 Million NZD | -42.92% |
| 2020 Q2 | -1.36 Million NZD | -100.0% |
| 2020 Q4 | -1.53 Million NZD | -112.01% |
| 2020 Q1 | -682.43 Thousand NZD | 0.0% |
| 2020 Q3 | -724.09 Thousand NZD | 46.95% |
| 2019 FY | -1.96 Million NZD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AFT Pharmaceuticals Limited | 15.6 Million NZD | 187.89% |
| Greenfern Industries Limited | -1.57 Million NZD | -772.303% |